These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 808355)

  • 1. [A protective antigen in the supernatant of Salmonella typhimurium cultures (strain M-206)].
    Ivanoff B; Creach O; Delorme P; Laval F; Fontanges R
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(6):791-3. PubMed ID: 808355
    [No Abstract]   [Full Text] [Related]  

  • 2. Compared efficiency of a killed vaccine of Salmonella typhimurium, a live vaccine and an antigenic fraction in oral immunization of mice.
    Fontanges R; Ivanoff B; Creach O
    Dev Biol Stand; 1976; 33():118-23. PubMed ID: 782961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunity to experimental salmonella infection and molecular-weight heterogeneity of antigenic complexes of S. typhimurium].
    Severtsova MK; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):79-85. PubMed ID: 324186
    [No Abstract]   [Full Text] [Related]  

  • 4. Localization of the protective antigen in Salmonella typhimurium.
    Mates A; Yosipovici H
    Microbios; 1976; 16(64):81-90. PubMed ID: 800632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an invertible DNA segment for improved antigen expression by a hybrid Salmonella vaccine strain.
    Yan ZX; Reuss F; Meyer TF
    Res Microbiol; 1990; 141(7-8):1003-4. PubMed ID: 2101464
    [No Abstract]   [Full Text] [Related]  

  • 6. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response against Salmonella typhimurium antigen fractions and protection.
    Calderon GM; Perez C; Ximenez C; Melendro EI
    Adv Exp Med Biol; 1995; 371B():1659-62. PubMed ID: 7502877
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficiency of porin as a component vaccine to Salmonella infection].
    Matsui K; Arai T
    Kansenshogaku Zasshi; 1993 Aug; 67(8):774-5. PubMed ID: 8409588
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel oral vaccines: the effectiveness of cloned gene products on inducing secretory immune responses.
    Katz J; Michalek SM; Curtiss R; Harmon C; Richardson G; Mestecky J
    Adv Exp Med Biol; 1987; 216B():1741-7. PubMed ID: 3321939
    [No Abstract]   [Full Text] [Related]  

  • 10. Intradermal vaccination against Salmonella typhimurium. Experimental study on mice.
    Dimache G; Gogulescu L; Tărbuc R; Dimache V
    Arch Roum Pathol Exp Microbiol; 1976 Jul; 35(3):265-8. PubMed ID: 798565
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protective efficacy of conjugates of bacterial antigen with synthetic polyelectrolytes].
    Petrov RV; Kabanov VA; Khaitov RM; Nekrasov AV; Alekseeva NIu
    Dokl Akad Nauk SSSR; 1983; 270(5):1257-9. PubMed ID: 6192981
    [No Abstract]   [Full Text] [Related]  

  • 12. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between protective immunity, mitogenicity, and B cell activiation by Salmonella vaccines.
    Eisenstein TK; Angerman CR; O'Donnell S; Specter S; Friedman H
    Adv Exp Med Biol; 1979; 121B():39-50. PubMed ID: 397755
    [No Abstract]   [Full Text] [Related]  

  • 15. Proteins from Salmonella R-mutants mediating protection against Salmonella typhimurium infection in mice. III. Separation and purification of soluble proteins and their use as vaccines and as precipitating antigens.
    Bhatnagar N; Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Dec; 260(4):448-58. PubMed ID: 3914792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
    Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
    J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis.
    Na HS; Kim HJ; Lee HC; Hong Y; Rhee JH; Choy HE
    Vaccine; 2006 Mar; 24(12):2027-34. PubMed ID: 16356600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Lon-deficient Salmonella strain as an oral vaccine candidate.
    Kodama C; Eguchi M; Sekiya Y; Yamamoto T; Kikuchi Y; Matsui H
    Microbiol Immunol; 2005; 49(12):1035-45. PubMed ID: 16365528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental protective immunization of mice against S. typhimurium infection by Salmonella R mutants].
    Schlecht S
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):250-6. PubMed ID: 4154594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.